Sarcoma and NeuroEndocrine Tumours


With emphasis on HPB
An international educational meeting

 

Thursday, 13th of December 2018 – GEPNET Day

 

08:00 – 08:45      Registration

Welcome

Manuel Maglione, Florian Primavesi, Stefan Stättner, D. Öfner-Velano (Director) - all Innsbruck

 

09:00 – 10:30      Introduction

Moderation: M. Massimo Falconi, Milan, Italy; Günther Krejs, Graz, Austria

       The landscape of NET in Austria (Florian Primavesi, Innsbruck, Austria)

       Epidemiology – true data or just better diagnostics? (Rainer Lipp, Graz, Austria)

       Nomenclature and classification of NET – do we all speak the same language? (Patrizia Kump, Graz, Austria)

       Functionality, syndromes and genetics (Susanne Kaser, Innsbruck, Austria)

       Keynote lecture – Pathology – what´s new, what´s hot? (Aurel Perren, Bern, Switzerland)

+ Discussion

Product Presentation Baxter Healthcare  - Coffee Break 10:30 – 11:00

 

11:00 – 12:10      II Assessment and biology GEPNET

Moderation: Aurel Perren, Bern, Switzerland; Patrizia Kump, Graz, Austria

       Tumour heterogeneity – a look inside (Daniel Neureiter, Salzburg, Austria)

       Predictive and personalized medicine – where are we today? (Jorge Barriuso, Manchester, UK)

       Future developments – NETomics? (Lukas Niederreiter, Innsbruck, Austria)       

       Nuclear diagnostic imaging – lighting the darkness (Christian Uprimny, Innsbruck, Austria)

+ Discussion

Lunch 12:10 – 13:10

 

13:10 – 14:40      III Treatment GEPNET/liver dominant disease

Moderation: Michael Silva, Oxford, UK; Markus Raderer, Vienna, Austria

       Keynote lecture – Cure, palliation or chronic disease (Marianne Pavel, Erlangen, Germany)

       Interventional strategies with curative intent (Reto Bale, Innsbruck, Austria)

       Interventional strategies with palliative intent (Johannes Petersen, Innsbruck, Austria)

       Treating the target – PRRT (Irene Virgolini, Innsbruck, Austria)

+ Discussion

Coffee Break 14:40 – 15:10

 

15:10 – 17:00      IV Treatment Part 2                                        

Moderation: Stephen Fenwick, Liverpool, UK; Marianne Pavel, Erlangen, Germany

       Systemic treatment – the role of chemotherapy (Angela Djanani, Innsbruck, Austria)

       The role of SSA Analogues/QoL (Barbara Kiesewetter, Vienna, Austria)

       Perioperative care (Philipp Riss, Vienna, Austria)       

       Future perspectives, trials (Stefano Partelli, Milan, Italy)

+ Discussion

       Keynote lecture – Outcomes of surgery in pNET (Massimo Falconi, Milan, Italy)

 

Welcome Drink after Session

Get together Dinner 19:00

Friday, 14th of December 2018

 

08:30 – 10:00      V Surgery GEPNET                                                This session is sponsored by                                 

Moderation: Marianne Pavel, Erlangen, Germany; Stefano Partelli, Milan, Italy

       Outcomes of Liver resection / debulking (Stephen Fenwick, Liverpool, UK)

       Liver transplantation for GEPNET – indications and outcomes (Rupert Oberhuber, Innsbruck, Austria)

       Is there a role for neoadjuvant/adjuvant treatments? (Markus Raderer, Vienna, Austria)

Moderation: Florian Primavesi, Innsbruck, Austria

       Cases and interactive discussion

Coffee Break 10:00 – 10:30

 

                                Sarcoma

                                                                                                                                                                       

 

10:30 – 12:00      Introduction                                                      

Moderation: Alessandro Gronchi, Milan, Italy; Arpad Sztankay, Innsbruck, Austria

       The landscape of sarcomas in Austria (Manuel Maglione, Innsbruck, Austria)       

       Keynote lecture – Definition, Graduation, classification (Alessandro Franchi, Pisa, Italy)         

       Epidemiology – a truly rare disease? (Alexander Perathoner, Innsbruck, Austria)

       Pathology – outline for clinicians (Georg Oberhuber, Innsbruck, Austria)

       Molecular Understanding (Amann Arno, Innsbruck, Austria)

       Do we always need a biopsy? (Andreas Seeber, Innsbruck, Austria)

+ Discussion

Lunch 12:00 – 13:00

 

13:00 – 14:10      II Assessment                                                    

Moderation: Stefan Stättner, Innsbruck, Austria;  Thomas Brodowicz, Vienna, Austria       

       Radiology – algorythms (Eva-Maria Gassner, Innsbruck, Austria)

       Nuclear and functional imaging (Christian Uprimny, Innsbruck, Austria)

       (Functional) assessment before surgery – what do we need? (Reinhold Kafka-Ritsch, Innsbruck, Austria)

       High volume for a rare disease – centralisation (Hassan Malik, Liverpool, UK)

+ Discussion

Coffee Break 14:10 – 14:40

 

14:40 – 17:00      III Treatment                                                       

Moderation: Alessandro Franchi, Pisa, Italy; Hassan Malik, Liverpool, UK

       The role of radiotherapy – pre, intra or postop? (Arpad Sztankay, Innsbruck, Austria)

       The role of systemic therapy (Thomas Brodowicz, Vienna, Austria)

       Liver surgery – indications and outcomes (Michael Silva, Oxford, UK)       

       Keynote lecture – What is the right surgery for abdominal/retroperitoneal sarcoma? (Alessandro Gronchi, Milan, Italy)

+ Discussion

Moderation: Manuel Maglione, Innsbruck, Austria

       Cases and interactive Board

 

17:00                     Closing remarks                                               

 

  

 

 

 

Accreditation

The meeting is accredited by
the Ärztekammer (Austrian Medical Association) to provide 17 DFP-Points.
---------------------------------------------------------------------------------------------------------------------------------------------------------------
The Surger-I-nnsbruck, Sarcoma and Neuroendocrine Tumours, Innsbruck, Austria, 13/12/2018-14/12/2018 LEE18-01604 has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 12 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.


Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at www.ama-assn.org/education/earn-credit-participation-international-activities.